Microdialysis monitoring of liver grafts by metabolic parameters, cytokine production, and complement activation

Transplantation

Volumn 86, Issue 8, 2008, Pages 1096-1103

  Wælgaard, Lars ^a   Thorgersen, Ebbe Billmann ^b   Line, Pål Dag ^b   Foss, Aksel ^b   Mollnes, Tom Eirik ^a,b   Tønnessen, Tor Inge ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Complement; Cytokine; Ischemia; Liver transplantation; Rejection

Indexed keywords

ALANINE AMINOTRANSFERASE; COMPLEMENT COMPONENT C5A; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; GLYCEROL; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRUVIC ACID; BIOLOGICAL MARKER; CYTOKINE; IL8 PROTEIN, HUMAN;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT OCCLUSION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER METABOLISM; LIVER TRANSPLANTATION; MICRODIALYSIS; MOLECULAR WEIGHT; POSTOPERATIVE INFLAMMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETRANSPLANTATION; SCHOOL CHILD; ARTIFICIAL MEMBRANE; FEMALE; GRAFT REJECTION; HEPATITIS; IMMUNOLOGY; INFANT; INSTRUMENTATION; LIVER; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MONITORING; THROMBOSIS; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMPLEMENT ACTIVATION; COMPLEMENT C5A; CYTOKINES; FEMALE; GRAFT REJECTION; HEPATITIS; HUMANS; INFANT; INTERLEUKIN-8; LIVER; LIVER TRANSPLANTATION; MALE; MEMBRANES, ARTIFICIAL; MICRODIALYSIS; MIDDLE AGED; MOLECULAR WEIGHT; MONITORING, PHYSIOLOGIC; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 55949130283     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818775ca     Document Type: Article

References (22)

1. Starzl TE. The mystique of organ transplantation. J Am Coll Surg 2005; 201: 160.
2. Wood RP, Ozaki CF, Katz SM, et al. Liver transplantation. The last ten years. Surg Clin North Am 1994; 74: 1133.
3. Hong Z, Wu J, Smart G, et al. Survival analysis of liver transplant patients in Canada 1997-2002. Transplant Proc 2006; 38: 2951.
4. Ozaki CF, Katz SM, Monsour HP Jr, et al. Surgical complications of liver transplantation. Surg Clin North Am 1994; 74: 1155.
5. Mueller AR, Platz KP, Kremer B. Early postoperative complications following liver transplantation. Best Pract Res Clin Gastroenterol 2004; 18: 881.
6. Nowak G, Ungerstedt J, Wernerman J, et al. Clinical experience in continuous graft monitoring with microdialysis early after liver transplantation. Br J Surg 2002; 89: 1169.
7. Silva MA, Richards DA, Bramhall SR,et al.Astudyofthe metabolites of ischemia-reperfusion injury and selected amino acids in the liver using microdialysis during transplantation. Transplantation 2005; 79: 828.
8. Silva MA, Murphy N, Richards DA, et al. Interstitial lactic acidosis in the graft during organ harvest, cold storage, and reperfusion of human liver allografts predicts subsequent ischemia reperfusion injury. Transplantation 2006; 82: 227.
9. Waelgaard L, Pharo A, Tønnessen TI, et al. Microdialysis for monitoring inflammation: Efficient recovery of cytokines and anaphylotoxins provided optimal catheter pore size and fluid velocity conditions. Scand J Immunol 2006; 64: 345.
10. Ungerstedt U. Microdialysis - A new technique for monitoring local tissue events in the clinic. Acta Anaesthesiol Scand Suppl 1997; 110: 123.
11. Nowak G, Ungerstedt J, Wernerman J, et al. Metabolic changes in the liver graft monitored continuously with microdialysis during liver transplantation in a pig model. Liver Transpl 2002; 8: 424.
12. Sjogren F, Svensson C, Anderson C. Technical prerequisites for in vivo microdialysis determination of interleukin-6 in human dermis. Br J Dermatol 2002; 146: 375.
13. Tsuchihashi S, Kaldas F, Chida N, et al. FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat liver transplantation. Am J Transplant 2006; 6: 2013.
14. Doherty JC, McMillen MA. Ischemic liver injury. J Am Coll Surg 1998; 186: 606.
15. Dahn MS, Lange MP, Berberoglu ED. Functional characteristics of the hypermetabolic isolated perfused liver. Shock 1996; 6: 52.
16. Yagihashi A, Zou XM, Hirata K, et al. Evaluation of serum IL-8 concentrations after orthotopic liver transplantation in rats. Transplant Proc 1995; 27: 1632.
17. Tilg H. Interleukin-8 serum concentrations after liver transplantation. Transplantation 1992; 53: 800.
18. Goddard S, Williams A, Morland C, et al. Differential expression of che-mokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 2001; 72: 1957.
19. Hauser IA, Spiegler S, Kiss E, et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol 2005; 16: 1849.
20. Matz M, Beyer J, Wunsch D, et al. Early post-transplant urinary IP-10 expression after kidney transplantationispredictiveof short- and long-term graft function. Kidney Int 2006; 69: 1683.
21. Zhu J, Xu ZK, Miao Y, et al. Changes of inducible protein-10 and regulated upon activation, normalTcell expressed and secreted protein in acute rejection of pancreas transplantation in rats. World J Gastro-enterol 2006; 12: 4156.
22. Lorho R, Turlin B, Aqodad N, et al. C4d: A marker for hepatic transplant rejection. Transplant Proc 2006; 38: 2333.